Tuesday, August 11, 2020

Very Brief Blog: CMS NCD on ctDNA for Colon Cancer Screening: Due August 28

CMS creates new preventive medicine benefits via National Coverage Determinations.  On February 28, 2020, CMS it was reviewing the FDA-approved Epi proCOlon test for coverage.  CMS: Here.   My blog:  here.  CMS took 30 days of public comment at that time (comments posted on CMS website). 

Heads up - the six month timeline for CMS to produce a proposed NCD is nearly passed.  The deadline is August 28.  Look for a proposed NCD from CMS on or around the 28th.



In the interval, in May 2020, AHRQ announced it was doing a broad review of the liquid biopsy space for detection and recurrence monitoring; my blog and links on that effort, here



Also in the past months, FDA held a one-day workshop on circulating tumor DNA for cancer screening, March 9, 2020.   Homepage here, 157 page transcript here.


CMS NCD Agenda:

click to enlarge